Sofinnova Management X-A, L.L.C. is Director & 10% Owner at Vera Therapeutics, Inc. (VERA). They have made 1 open-market trade across 1 company since 2023, most recently 2023-02-06.
CIK 0001965187
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.0M since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VERA | 3,467,156 | $96.7M |
Shares reported on the most recent Form 4, priced at the 2023-02-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VERA | BUY | 2023-02-06 | 2023-02-08 | $7.00 | $2.0M | +4.0% | -4.7% | -1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.